Financials of Divis Laboratories Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Divis Laboratories Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +1,9511,7781,9091,8552,3032,1182,3382,3192,5852,4102,7152,6042,831
Expenses +1,4641,2741,4301,3661,5721,4961,6221,5761,6991,6811,8271,7141,897
Operating Profit487504479489731622716743886729888890934
OPM %25%28%25%26%32%29%31%32%34%30%33%34%33%
Other Income +668186957979106828611914514155
Interest0010201013866
Depreciation8793959595979999107112113118120
Profit before tax466492469489713604722726864733912780963
Tax %31%28%26%27%25%29%29%19%23%26%24%25%22%
Net Profit +321356348358538430510589662545689583751
EPS in Rs12.0913.4113.1113.4920.2716.2019.2122.1924.9420.5325.9521.9628.29

Financials of Divis Laboratories Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +3,1153,7764,0643,8914,9465,3946,9698,9607,7687,8459,36010,560
Expenses +1,9422,3542,6152,6223,0723,5684,1025,0755,3975,6356,3877,119
Operating Profit1,1731,4231,4501,2691,8741,8262,8673,8852,3702,2102,9733,441
OPM %38%38%36%33%38%34%41%43%31%28%32%33%
Other Income +38937210715418657112344335348433
Interest3532572224323
Depreciation136118123142169186256312343378402463
Profit before tax1,0721,3931,3951,2311,8551,8192,6663,6842,3692,1632,9163,388
Tax %21%19%24%29%27%24%26%20%23%26%25%24%
Net Profit +8521,1261,0608771,3531,3771,9842,9601,8231,6002,1912,568
EPS in Rs32.0742.4139.9533.0450.9651.8574.75111.5268.6960.2782.5396.73
Dividend Payout %31%24%25%30%31%31%27%27%44%50%36%31%

Financials of Divis Laboratories Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital275353535353535353535353
Reserves3,4694,2405,3045,8726,9047,2579,24211,67512,71413,51814,91616,708
Borrowings +2742366310639543347
Other Liabilities +8835627627979731,1831,4711,6281,6541,8861,9483,265
Total Liabilities4,4054,8986,1556,7858,0368,53110,77113,36014,42515,46016,92120,033
Fixed Assets +1,3091,4391,5591,9962,0882,7823,7044,3254,7234,7395,4426,528
CWIP2182644441204929207114702127781,0222,113
Investments7338031,6311,8891,94697107277826569
Other Assets +2,1452,3922,5212,7803,5113,8586,3568,4939,4139,86110,39211,323
Total Assets4,4054,8986,1556,7858,0368,53110,77113,36014,42515,46016,92120,033

Financials of Divis Laboratories Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +8261,0381,1507769541,2161,9471,9122,4601,2611,6532,738
Cash from Investing Activity +-521-406-1,140-478-685-8375-2,195-2,708-269-804-2,219
Cash from Financing Activity +-303-6312-314-246-1,091-35-532-797-799-799-804
Net Cash Flow3013-1723411,987-816-1,04519350-285
Free Cash Flow519642774502221331,0371,1991,987258215221
CFO/OP88%91%100%82%77%91%90%66%124%74%83%105%

Financials of Divis Laboratories Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days878581958696889984100106103
Inventory Days350293307314347316329341352364311353
Days Payable6856104969610011796899488108
Cash Conversion Cycle368322284313336312300344347370330348
Working Capital Days140158147176169180152177188206192195
ROCE %33%36%29%22%29%25%32%35%19%16%20%22%